MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 597265 | Name: Aspartylglutamate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Aspartylglutamate is a precursor molecule which upon acetylation to N-acetyl-aspartyl-glutamate (NAAG) is used as a metabotropic glutamate mGlu receptor agonist.

Chemical Structure

Aspartylglutamate
Aspartylglutamate
CAS#6157-06-8

Theoretical Analysis

MedKoo Cat#: 597265

Name: Aspartylglutamate

CAS#: 6157-06-8

Chemical Formula: C9H14N2O7

Exact Mass: 262.0801

Molecular Weight: 262.21

Elemental Analysis: C, 41.22; H, 5.38; N, 10.68; O, 42.71

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Aspartylglutamate; Asp-glu;
IUPAC/Chemical Name
L-aspartyl-L-glutamic acid
InChi Key
CKAJHWFHHFSCDT-WHFBIAKZSA-N
InChi Code
InChI=1S/C9H14N2O7/c10-4(3-7(14)15)8(16)11-5(9(17)18)1-2-6(12)13/h4-5H,1-3,10H2,(H,11,16)(H,12,13)(H,14,15)(H,17,18)/t4-,5-/m0/s1
SMILES Code
O=C(O)CC[C@@H](C(O)=O)NC([C@H](CC(O)=O)N)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 262.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Wang YY, Li YD, Liu JB, Ran XX, Guo YY, Ren NN, Chen X, Jiang H, Li YQ. Characterization and evolutionary implications of the triad Asp-Xxx-Glu in group II phosphopantetheinyl transferases. PLoS One. 2014 Jul 18;9(7):e103031. doi: 10.1371/journal.pone.0103031. eCollection 2014. PubMed PMID: 25036863; PubMed Central PMCID: PMC4103896. 2: Cuchra M, Szaflik JP, Przybylowska-Sygut K, Gacek M, Kaminska A, Szaflik J, Majsterek I. The role of the 148 Asp/Glu polymorphism of the APE1 gene in the development and progression of primary open angle glaucoma development in the Polish population. Pol J Pathol. 2013 Dec;64(4):296-302. PubMed PMID: 24375045. 3: Vavrusova M, Skibsted LH. Calcium binding to dipeptides of aspartate and glutamate in comparison with orthophosphoserine. J Agric Food Chem. 2013 Jun 5;61(22):5380-4. doi: 10.1021/jf400741e. Epub 2013 May 24. PubMed PMID: 23682986. 4: Baslow MH, Guilfoyle DN. Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions. Biochimie. 2013 Apr;95(4):946-56. doi: 10.1016/j.biochi.2012.10.023. Epub 2012 Nov 11. PubMed PMID: 23151389. 5: Lázaro L, Bargalló N, Andrés S, Falcón C, Morer A, Junqué C, Castro-Fornieles J. Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment. Psychiatry Res. 2012 Jan 30;201(1):17-24. doi: 10.1016/j.pscychresns.2011.01.017. Epub 2012 Jan 24. PubMed PMID: 22281202. 6: Collard F, Vertommen D, Constantinescu S, Buts L, Van Schaftingen E. Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3. J Biol Chem. 2011 Nov 4;286(44):38220-30. doi: 10.1074/jbc.M111.287318. Epub 2011 Sep 9. PubMed PMID: 21908619; PubMed Central PMCID: PMC3207455. 7: Grella B, Adams J, Berry JF, Delahanty G, Ferraris DV, Majer P, Ni C, Shukla K, Shuler SA, Slusher BS, Stathis M, Tsukamoto T. The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II. Bioorg Med Chem Lett. 2010 Dec 15;20(24):7222-5. doi: 10.1016/j.bmcl.2010.10.109. Epub 2010 Oct 26. PubMed PMID: 21074428. 8: Benneyworth MA, Basu AC, Coyle JT. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Psychopharmacology (Berl). 2011 Jan;213(1):143-53. doi: 10.1007/s00213-010-2023-4. Epub 2010 Sep 24. PubMed PMID: 20865248; PubMed Central PMCID: PMC4818544. 9: Prescot A, Becerra L, Pendse G, Tully S, Jensen E, Hargreaves R, Renshaw P, Burstein R, Borsook D. Excitatory neurotransmitters in brain regions in interictal migraine patients. Mol Pain. 2009 Jun 30;5:34. doi: 10.1186/1744-8069-5-34. PubMed PMID: 19566960; PubMed Central PMCID: PMC2714306. 10: Klusák V, Barinka C, Plechanovová A, Mlcochová P, Konvalinka J, Rulísek L, Lubkowski J. Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods. Biochemistry. 2009 May 19;48(19):4126-38. doi: 10.1021/bi900220s. PubMed PMID: 19301871. 11: Gimenez M, Soria-Pastor S, Junque C, Caldu X, Narberhaus A, Botet F, Bargallo N, Falcon C, Mercader JM. Proton magnetic resonance spectroscopy reveals medial temporal metabolic abnormalities in adolescents with history of preterm birth. Pediatr Res. 2008 Nov;64(5):572-7. doi: 10.1203/PDR.0b013e3181841eab. PubMed PMID: 18596571. 12: Singh AK, Gupta S, Jiang Y. Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120. J Neurochem. 2008 Mar;104(6):1478-93. Epub 2007 Dec 6. PubMed PMID: 18067547. 13: Gustafsson MC, Dahlqvist O, Jaworski J, Lundberg P, Landtblom AM. Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. AJNR Am J Neuroradiol. 2007 Aug;28(7):1306-12. PubMed PMID: 17698533. 14: Tsai SJ. Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia. Med Sci Monit. 2005 Sep;11(9):HY39-45. Epub 2005 Aug 26. Review. PubMed PMID: 16127367. 15: Malomouzh AI, Nikolsky EE, Lieberman EM, Sherman JA, Lubischer JL, Grossfeld RM, Urazaev AKh. Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat. J Neurochem. 2005 Jul;94(1):257-67. PubMed PMID: 15953368. 16: Tsai SJ. Strategies to increase central N-acetyl aspartylglutamate: a potential treatment for schizophrenia and bipolar disorders. Schizophr Res. 2005 Jul 15;76(2-3):359-60. PubMed PMID: 15949670. 17: Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, Pouwels PJ. Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J Magn Reson Imaging. 2004 Sep;20(3):366-71. PubMed PMID: 15332241. 18: Santoro L, Manganelli F, Di Maria E, Bordo D, Cassandrini D, Ajmar F, Mandich P, Bellone E. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease. J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):262-5. PubMed PMID: 14742601; PubMed Central PMCID: PMC1738925. 19: Liu C, Huang H, Doñate F, Dickinson C, Santucci R, El-Sheikh A, Vessella R, Edgington TS. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res. 2002 Oct 1;62(19):5470-5. PubMed PMID: 12359755. 20: Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol. 2002 Jan;51(1):51-8. PubMed PMID: 11782984. a